First Alzheimer’s commercial blood test to detect amyloid beta hits the market
A new blood test that detects the presence of Alzheimer’s brain plaques on Thursday became the first to hit the commercial market on a wide scale.
A new blood test that detects the presence of Alzheimer’s brain plaques on Thursday became the first to hit the commercial market on a wide scale.
A pilot study in one Rhode Island health system is testing a telemedicine system to improve depression in nursing home rehabilitation residents.